Galapagos receives transparency notification from FMR LLC
09 August 2022 - 6:01AM
Galapagos receives transparency notification from FMR LLC
Mechelen, Belgium; 8
August 2022,
22.01
CET; regulated information – Galapagos NV
(Euronext & NASDAQ: GLPG) received a transparency notification
from FMR LLC.
Pursuant to Belgian transparency legislation1,
Galapagos received a transparency notification on 3 August 2022
from FMR LLC, who notified that it holds 3,739,645 of Galapagos’
voting rights, consisting of ordinary shares (3,707,145) and
equivalent financial instruments (32,500). FMR LLC controls
investment funds FIAM Holdings LLC, Fidelity Management &
Research Company LLC, Fidelity Management Trust Company and
Strategic Advisers LLC, of which Fidelity Management & Research
Company LLC increased its position to 3,300,782 voting rights,
consisting of ordinary shares (3,268,282) and equivalent financial
instruments (32,500), representing 5.02% of Galapagos' currently
outstanding shares. Hence, this controlled undertaking of FMR LLC
group individually crossed the 5% threshold. FMR LLC's holding of
3,739,645 Galapagos' voting rights now represents 5.69% of
Galapagos' currently outstanding 65,728,511 shares. FMR LLC thus
remains above the 5% threshold of Galapagos’ voting rights by
acquisition of voting securities on 29 July 2022. The full
transparency notice is available on the Galapagos website.
About
GalapagosGalapagos is a fully integrated biotechnology
company focused on discovering, developing, and commercializing
innovative medicines. We are committed to improving patients’ lives
worldwide by targeting diseases with high unmet needs. Our R&D
capabilities cover multiple drug modalities, including small
molecules and cell therapies. Our portfolio comprises discovery
through to Phase 3 programs in inflammation, oncology, fibrosis,
and other indications. Our first medicine for rheumatoid arthritis
and ulcerative colitis is approved and available in the European
Union (including Norway), Great Britain and Japan. For additional
information, please visit www.glpg.com or follow us on LinkedIn or
Twitter.
ContactInvestors:Sofie
Van GijselHead of Investor Relations +1 781 296 1143
Sandra CauwenberghsDirector Investor Relations+32 495 58 46
63ir@glpg.com
Media:Marieke VermeerschHead of Corporate
Communication+32 479 490 603media@glpg.com
1 Belgian Act of 2 May 2007 on the
disclosure of major shareholdings in issuers whose shares are
admitted to trading on a regulated market
- Galapagos receives transparency notification from FMR LLC
Galapagos (TG:GXE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Galapagos (TG:GXE)
Historical Stock Chart
From Oct 2023 to Oct 2024